Application of recombinant peroxisome proliferator‑activated receptor‑γ coactivator‑1α mediates neovascularization in the retina

  • Authors:
    • Jian Jiang
    • Lixin Zhang
    • Lu Zhang
    • Xiaobo Xia
  • View Affiliations

  • Published online on: December 11, 2015     https://doi.org/10.3892/mmr.2015.4678
  • Pages: 1311-1319
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Peroxisome proliferator‑activated receptor‑γ coactivator‑1α (PGC‑1α) is able to induce the expression of vascular endothelial growth factor (VEGF), promoting the formation of new blood vessels in skeletal muscle. The aim of the current study was to determine whether PGC‑1α is able to regulate angiogenesis in human retinal vascular endothelial cells (hRVECs) in vitro and in retinas in vivo. hRVECs treated with recombinant PGC‑1α were incubated for 24 h and then placed into a normoxic (20% O2) or hypoxic (1% O2) environment for a further 16 h. Following this, VEGF mRNA and protein levels were significantly increased. Cellular proliferation was enhanced by treatment with recombinant PGC‑1α in normoxic and hypoxic conditions. At 24 h following recombinant PGC‑1α treatment, hRVECs were plated into Matrigel‑coated plates and cultured under normoxic (20% O2) or hypoxic (1% O2) conditions for a further 24 h. Recombinant PGC‑1α‑treated cells were observed to form significantly greater numbers of tubes. In a C57BL/6J mouse model of ischemic retinopathy, mice received an intravitreal injection of recombinant PGC‑1α, resulting in a significant increase in VEGF mRNA and protein levels in the retina. Retinal neovascular tufts and neovascular nuclei were investigated by angiographic and cross‑sectional analysis and were observed to be significantly increased in the PGC‑1α group compared with the control group. These results indicate that PGC‑1α is able to induce angiogenesis in hRVECs and retinas, and suggests that PGC‑1α is a potential anti‑angiogenic target in retinal neovascularization.
View Figures
View References

Related Articles

Journal Cover

February-2016
Volume 13 Issue 2

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Jiang J, Zhang L, Zhang L and Xia X: Application of recombinant peroxisome proliferator‑activated receptor‑γ coactivator‑1α mediates neovascularization in the retina. Mol Med Rep 13: 1311-1319, 2016
APA
Jiang, J., Zhang, L., Zhang, L., & Xia, X. (2016). Application of recombinant peroxisome proliferator‑activated receptor‑γ coactivator‑1α mediates neovascularization in the retina. Molecular Medicine Reports, 13, 1311-1319. https://doi.org/10.3892/mmr.2015.4678
MLA
Jiang, J., Zhang, L., Zhang, L., Xia, X."Application of recombinant peroxisome proliferator‑activated receptor‑γ coactivator‑1α mediates neovascularization in the retina". Molecular Medicine Reports 13.2 (2016): 1311-1319.
Chicago
Jiang, J., Zhang, L., Zhang, L., Xia, X."Application of recombinant peroxisome proliferator‑activated receptor‑γ coactivator‑1α mediates neovascularization in the retina". Molecular Medicine Reports 13, no. 2 (2016): 1311-1319. https://doi.org/10.3892/mmr.2015.4678